Biomaterial Database

Gout and pseudogout. 1993

A K Agarwal

Rheumatology Services, Medical Center, Beaver, Pennsylvania.

This article describes the clinical spectrum of gout and pseudogout and discusses the role of colchicine, NSAIDs, and uric acid--lowering agents in the management of different stages of gout. A great majority of patients with gout are now seen and treated by primary care physicians. Strategy for successful management of gout and prevention of its disabling complications are discussed also.

UI	MeSH Term	Description	Entries
D002805	Chondrocalcinosis	Presence of CALCIUM PYROPHOSPHATE in the connective tissues such as the cartilaginous structures of joints. When accompanied by GOUT-like symptoms, it is referred to as pseudogout.	Calcium Pyrophosphate Dihydrate Deposition,Pseudogout,Calcium Pyrophosphate Deposition Disease,Chondrocalcinoses
D003937	Diagnosis, Differential	Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures.	Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D006073	Gout	Metabolic disorder characterized by recurrent acute arthritis, hyperuricemia and deposition of sodium urate in and around the joints, sometimes with formation of URIC ACID calculi.	Gouts
D006801	Humans	Members of the species Homo sapiens.	Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015210	Arthritis, Gouty	Arthritis, especially of the great toe, as a result of gout. Acute gouty arthritis often is precipitated by trauma, infection, surgery, etc. The initial attacks are usually monoarticular but later attacks are often polyarticular. Acute and chronic gouty arthritis are associated with accumulation of MONOSODIUM URATE in and around affected joints.	Gouty Arthritis,Arthritides, Gouty,Gouty Arthritides